AstraZeneca's revenue from Crestor by region 2018-2023
This statistic describes AstraZeneca's revenue from one of its top products, Crestor, by region from 2018 to 2023. In 2023, the revenue from Crestor was the highest in emerging markets, with 862 million U.S. dollars. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.